The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face competition from cheaper generics.
Related Posts
Investment banks lift China growth outlook after surprise trade deal with U.S.
Global banks are reviewing their China calls after the thawing of trade relations between Washington and Beijing.
The Nasdaq has dropped 4% over the past week. Here’s why that may not be a big red flag
Tax considerations and a shift away from tech are two possible reasons why the weakness in the Nasdaq is not a bad omen for the […]
Morgan Stanley is due to release fourth-quarter earnings
The bank’s massive wealth management business will be helped by high stock market values in the fourth quarter, which inflates the management fees it collects.